Android app Apple app link

Summit Therapeutics Inc. (SMMT) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$14.98
Day's range
$15.88

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
09/29/2026 Goldman Sachs Satoru Ogawa $41.00 $15.48   164.86%
09/29/2026 Jefferies Faisal Khurshid $30.00 $15.48   93.8%
09/09/2026 Summit Redstone Partners Faisal Khurshid $25.00 $17.28   44.68%
09/08/2026 UBS David Dai $33.00 $17.27   91.03%
08/25/2026 Summit Redstone Partners Jeffrey Walch $11.90 $12.73   -6.52%
07/24/2026 Stifel Nicolaus Dara Azar $38.00 $14.98   153.67%
07/24/2026 Guggenheim Brad Canino $38.00 $14.98   153.67%
12/17/2025 Summit Redstone Partners Etzer Darout $18.00 $17.23   4.47%
08/19/2025 Summit Redstone Partners Kelsey Goodwin $21.00 $25.71   -18.32%
04/25/2025 Jefferies Kelly Shi $44.00 $25.61   71.84%
03/26/2025 Summit Redstone Partners Yigal Nochomovitz $35.00 $19.89   75.97%
11/04/2024 JMP Securities Reni Benjamin $32.00 $19.96   60.32%
09/27/2024 Summit Redstone Partners Yigal Nochomovitz $23.00 $20.89   10.13%
09/25/2024 Stifel Nicolaus Brad Canino $40.00 $24.00   66.67%
09/16/2024 H.C. Wainwright Mitchell Kapoor $45.00 $31.93   40.93%
06/03/2024 Stifel Nicolaus Brad Canino $14.00 $8.69   61.2%
03/25/2024 Stifel Nicolaus Brad Canino $8.00 $3.28   143.9%

Summit Therapeutics Inc FAQ's

Summit Therapeutics Inc has been rated by research analysts at Barclays, Goldman Sachs, Jefferies, Summit Redstone Partners, UBS, Stifel Nicolaus in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.